Clinical Trial Update: Efficacy and Safety of Insulin Degludec/Insulin Aspart in Insulin-naïve Subjects With Type 2 Diabetes Using Two Dosing Regimens [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated the efficacy and safety of the insulin degludec/insulin aspart combination in insulin-naïve adults with type 2 diabetes using two dosi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Ryzodeg 70/30 (insulin degludec/insulin aspart)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED | Results posted: 2015-11-20